The expression of BMP4 showed an escalating trend as the pathological stage progressing (Figure 1B) but was not significantly affected by the age, gender, and recurrent status of PAAD patients (Supplementary Figure S3A-C). This evidence concerns the gene BMP4 and pancreatic adenocarcinoma.